CL-82198
SIGMA/C9498 - ≥98% (HPLC), powder
Synonym: N-
CAS Number: 307002-71-7
Empirical Formula (Hill Notation): C17H22N2O3
Molecular Weight: 302.37
MDL Number: MFCD12828877
Linear Formula: C17H22N2O3
Product Type: Chemical
| assay | ≥98% (HPLC) |
| color | white to off-white |
| form | powder |
| InChI | 1S/C17H22N2O3/c20-17(16-1 |
| InChI key | KUJQEQAVMNFFAO-UHFFFAOYSA |
| originator | Wyeth |
| Quality Level | 100 ![]() |
| SMILES string | O=C(NCCCCN1CCOCC1)c2cc3cc |
| solubility | DMSO: >10 mg/mL |
| storage temp. | 2-8°C |
| Biochem/physiol Actions: | CL-82198 is a selective inhibitor of MMP-13 that displays no activity at MMP-1, MMP-9 or TACE. It is also a selective S1′ pocket binder, binding within the entire S1′ pocket of MMP-13, docking with the morpholine ring adjacent to the catalytic zinc atom without zinc chelation. |
| Biochem/physiol Actions: | CL-82198 is a selective inhibitor of MMP-13 that displays no activity at MMP-1, MMP-9 or TACE. It is also a selective S1′ pocket binder. |
| Features and Benefits: | This compound was developed by Wyeth . To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here . |
| Packaging: | 5, 25 mg in glass bottle |
| Symbol | GHS07 |
| Signal word | Warning |
| Hazard statements | H302 |
| Hazard Codes | Xn |
| Risk Statements | 22 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥98% (HPLC) |
| Storage Temp. | 2-8°C |
| UNSPSC | 12352200 |


